AMYLIN PHARMACEUTICALS INC 4
4 · AMYLIN PHARMACEUTICALS INC · Filed Oct 2, 2007
Insider Transaction Report
Form 4
BARON ALAIN D
Sr VP Research
Transactions
- Exercise/Conversion
Common Stock
2007-10-01$7.19/sh+2,000$14,375→ 17,847 total - Sale
Common Stock
2007-10-01$49.80/sh−2,000$99,590→ 15,847 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2007-10-01−2,000→ 38,616 totalExercise: $7.19Exp: 2009-12-08→ Common Stock (2,000 underlying) - Sale
Common Stock
2007-10-01$49.83/sh−1,000$49,830→ 15,847 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2007-10-01−1,000→ 40,616 totalExercise: $7.19Exp: 2009-12-08→ Common Stock (1,000 underlying) - Exercise/Conversion
Common Stock
2007-10-01$7.19/sh+1,000$7,188→ 16,847 total
Footnotes (2)
- [F1]This sale was affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]15,275 options vested on 12/08/2000, and daily after that, until all the 95,000 options were completely vested on 12/08/2003.